Literature DB >> 33778596

MRI Characteristics, Prevalence, and Outcomes of Hypertrophic Cardiomyopathy with Restrictive Phenotype.

Shuang Li1, Bailing Wu1, Gang Yin1, Lei Song1, Yong Jiang1, Jinghan Huang1, Shihua Zhao1, Minjie Lu1.   

Abstract

PURPOSE: To investigate the MRI characteristics, prevalence, and outcomes of hypertrophic cardiomyopathy (HCM) with restrictive phenotype.
MATERIALS AND METHODS: A total of 2592 consecutive patients with HCM were evaluated to identify individuals who fulfilled the diagnostic criteria of restrictive phenotype. Thirty-four patients with HCM (mean age, 41 years ± 16 [standard deviation]; range, 21-62 years, 16 men) with restrictive phenotype were retrospectively identified. Thirty-four patients with HCM with the same age and sex distributions were randomly selected as a control group. Kaplan-Meier survival curves were compared using log-rank statistics for survival analysis.
RESULTS: The anteroposterior diameters of the left and right atria were 55 mm ± 5 and 61 mm ± 9, respectively, which were larger than those of the control group (P < .001). The maximum wall thickness in the restrictive group was lower than that in the control group (16 mm ± 2 vs 19 mm ± 3, P < .001). No significant difference was found in late gadolinium enhancement fraction between the restricted phenotype and the control group (15% ± 8 vs 13% ± 7, P = .376). The 5-year event-free survival from any cause of death and cardiac transplantation was 81% in the restrictive group, compared with 94% in the control group (log-rank P = .018).
CONCLUSION: Restrictive phenotype is a rare subtype of HCM and is associated with severe clinical symptoms and poor prognosis. The MRI features of this phenotype include mild to moderate left ventricular hypertrophy, markedly enlarged atria, moderate myocardial fibrosis, and pericardial effusion.© RSNA, 2020. 2020 by the Radiological Society of North America, Inc.

Entities:  

Year:  2020        PMID: 33778596      PMCID: PMC7977807          DOI: 10.1148/ryct.2020190158

Source DB:  PubMed          Journal:  Radiol Cardiothorac Imaging        ISSN: 2638-6135


  30 in total

1.  Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography.

Authors:  Miguel A Quiñones; Catherine M Otto; Marcus Stoddard; Alan Waggoner; William A Zoghbi
Journal:  J Am Soc Echocardiogr       Date:  2002-02       Impact factor: 5.251

Review 2.  Sudden death in young athletes.

Authors:  Barry J Maron
Journal:  N Engl J Med       Date:  2003-09-11       Impact factor: 91.245

3.  Contemporary evaluation and management of hypertrophic cardiomyopathy.

Authors:  Eugene Braunwald; Christine E Seidman; Ulrich Sigwart
Journal:  Circulation       Date:  2002-09-10       Impact factor: 29.690

4.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

Authors:  B J Maron; I Olivotto; P Spirito; S A Casey; P Bellone; T E Gohman; K J Graham; D A Burton; F Cecchi
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

5.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Authors:  Perry M Elliott; Aris Anastasakis; Michael A Borger; Martin Borggrefe; Franco Cecchi; Philippe Charron; Albert Alain Hagege; Antoine Lafont; Giuseppe Limongelli; Heiko Mahrholdt; William J McKenna; Jens Mogensen; Petros Nihoyannopoulos; Stefano Nistri; Petronella G Pieper; Burkert Pieske; Claudio Rapezzi; Frans H Rutten; Christoph Tillmanns; Hugh Watkins
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

6.  Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics.

Authors:  S S Lele; H L Thomson; H Seo; I Belenkie; W J McKenna; M P Frenneaux
Journal:  Circulation       Date:  1995-11-15       Impact factor: 29.690

7.  Predictors of Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: An Echocardiography and Cardiovascular Magnetic Resonance Imaging Study.

Authors:  Minjie Lu; Hui Du; Zhan Gao; Lei Song; Huaibing Cheng; Yan Zhang; Gang Yin; Xiuyu Chen; Jian Ling; Yong Jiang; Hao Wang; Jinghui Li; Jinghan Huang; Zuoxiang He; Shihua Zhao
Journal:  Circ Cardiovasc Interv       Date:  2016-03       Impact factor: 6.546

Review 8.  Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy.

Authors:  Amit R Patel; Christopher M Kramer
Journal:  JACC Cardiovasc Imaging       Date:  2017-10

9.  [Atypical forms of hypertrophic cardiomyopathy].

Authors:  J Piotrowska; Z T Bilińska; E Michalak; W Ruzyłło; W Rydlewska-Sadowska
Journal:  Kardiol Pol       Date:  1991       Impact factor: 3.108

Review 10.  Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Martin S Maron
Journal:  J Cardiovasc Magn Reson       Date:  2012-02-01       Impact factor: 5.364

View more
  3 in total

1.  Multimodality imaging of cor triatriatum dexter complicated with hypertrophic cardiomyopathy of restrictive phenotype.

Authors:  Li Liang; Min-Jie Lu
Journal:  Radiol Case Rep       Date:  2022-05-28

2.  Diagnostic performance of CT lung severity score and quantitative chest CT for stratification of COVID-19 patients.

Authors:  Damiano Caruso; Marta Zerunian; Michela Polici; Francesco Pucciarelli; Gisella Guido; Tiziano Polidori; Carlotta Rucci; Benedetta Bracci; Giuseppe Tremamunno; Andrea Laghi
Journal:  Radiol Med       Date:  2022-02-14       Impact factor: 3.469

3.  Case Report: Two New Cases of Autosomal-Recessive Hypertrophic Cardiomyopathy Associated With TRIM63-Compound Heterozygous Variant.

Authors:  Sofiya Andreeva; Olga Chumakova; Elena Karelkina; Viktoriya Lebedeva; Tamara Lubimtseva; Andrey Semenov; Alexey Nikitin; Gleb Speshilov; Alexandra Kozyreva; Polina Sokolnikova; Sergey Zhuk; Yuliya Fomicheva; Olga Moiseeva; Anna Kostareva
Journal:  Front Genet       Date:  2022-02-22       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.